Correlation Between Day One and Gain Therapeutics
Can any of the company-specific risk be diversified away by investing in both Day One and Gain Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Gain Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Gain Therapeutics, you can compare the effects of market volatilities on Day One and Gain Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Gain Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Gain Therapeutics.
Diversification Opportunities for Day One and Gain Therapeutics
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Day and Gain is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Gain Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gain Therapeutics and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Gain Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gain Therapeutics has no effect on the direction of Day One i.e., Day One and Gain Therapeutics go up and down completely randomly.
Pair Corralation between Day One and Gain Therapeutics
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.41 times more return on investment than Gain Therapeutics. However, Day One Biopharmaceuticals is 2.44 times less risky than Gain Therapeutics. It trades about -0.09 of its potential returns per unit of risk. Gain Therapeutics is currently generating about -0.25 per unit of risk. If you would invest 1,460 in Day One Biopharmaceuticals on August 26, 2024 and sell it today you would lose (88.00) from holding Day One Biopharmaceuticals or give up 6.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Gain Therapeutics
Performance |
| Timeline |
| Day One Biopharmaceu |
| Gain Therapeutics |
Day One and Gain Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Gain Therapeutics
The main advantage of trading using opposite Day One and Gain Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Gain Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gain Therapeutics will offset losses from the drop in Gain Therapeutics' long position.| Day One vs. Eliem Therapeutics | Day One vs. HCW Biologics | Day One vs. Scpharmaceuticals | Day One vs. Milestone Pharmaceuticals |
| Gain Therapeutics vs. Biovie Inc | Gain Therapeutics vs. In8bio Inc | Gain Therapeutics vs. NewAmsterdam Pharma | Gain Therapeutics vs. Cue Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |